MI Outcomes May Be Worse in Patients With Rheumatic IMID

FRIDAY, Sept. 23, 2022 -- The risks for mortality, heart failure, and recurrent myocardial infarction (MI) and the need for coronary reintervention are increased for patients with MI and rheumatic immune-mediated inflammatory diseases (IMIDs),...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news